SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Unigene Lab. (UGNE) -- Ignore unavailable to you. Want to Upgrade?

To: Toni Wheeler who wrote (326)6/24/1999 2:38:00 AM
From: Ralph Hueppin  Respond to of 347
 
First of all, this patent announcement is a non-event. It
was long awaited. Second, The compound is not even in phase I
of the clinical studies. therefore you wont see a product
for 4-5 years from now. (this is about the mean of a clinical
cicle). BTW only about every 5000th compound which enters the clinic makes it to the shelves so don't be to optimistic about this.
In the meantime there are some other firm which are far more
advanced for an oral osteoporosis product.

-ralph


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News